Cover Image

Feasibility and acceptability of integrating mass distribution of azithromycin to children 1-11 months into a trachoma mass drug administration campaign to reduce child mortality in Côte d'Ivoire

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Lisa Dulli (Author), Fatoumata Touré (Author), Adam Djima Mama (Author), Emily Evens (Author), Kate Murray (Author), Norbert N'goran Djè (Author), Stéphane Koné (Author), Pat Sadate-Ngatchou (Author), Anoma Bovary (Author), Marga Eichleay (Author), Milenka Jean-Baptiste (Author), Aboulaye Méité (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Feasibility and acceptability of integrating mass distribution of azithromycin to children 1-11 months into a trachoma mass drug administration campaign to reduce child mortality in Côte d'Ivoire.
by: Lisa Dulli, et al.
Published: (2024)

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
by: Agodio Loukouri, et al.
Published: (2020)

A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d'Ivoire and Uganda
by: Daniel Dilliott, et al.
Published: (2022)

A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d'Ivoire and Uganda.
by: Daniel Dilliott, et al.
Published: (2022)

Schistosomiasis, soil-transmitted helminthiasis, and sociodemographic factors influence quality of life of adults in Côte d'Ivoire.
by: Thomas Fürst, et al.
Published: (2012)

Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010)

Serology for trachoma surveillance after cessation of mass drug administration.
by: Diana L Martin, et al.
Published: (2015)

Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria.
by: Elizabeth A Cromwell, et al.
Published: (2013)

Mass drug administration for trachoma: how long is not long enough?
by: Violeta Jimenez, et al.
Published: (2015)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws.
by: Michael Marks, et al.
Published: (2015)

Stopping azithromycin mass drug administration for trachoma: A systematic review.
by: Hamidah Mahmud, et al.
Published: (2021)

Determinants of Modern Paediatric Healthcare Seeking in Rural Côte d'Ivoire
by: Siaka Koné, et al.
Published: (2022)

Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study.
by: Obiora A Eneanya, et al.
Published: (2021)

The cost of mass drug administration for trachoma in two counties of the Republic of South Sudan.
by: Tim Jesudason, et al.
Published: (2024)

A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
by: Sheila K West, et al.
Published: (2013)

Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma
by: Fraser-Hurt Nicole, et al.
Published: (2001)

Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol
by: Yves-Nathan T, et al.
Published: (2018)

Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
by: Rufin K Assaré, et al.
Published: (2016)

Adaptation of an electronic dashboard to monitor HIV viral load testing in Côte d'Ivoire
by: Mary Kirk, et al.
Published: (2021)

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.
by: Tansy Edwards, et al.
Published: (2014)

Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
by: Takele Lakew, et al.
Published: (2009)

The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan.
by: Jan H Kolaczinski, et al.
Published: (2011)

Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children
by: Frick Kevin D., et al.
Published: (2001)

Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.
by: Jonathan D King, et al.
Published: (2014)

Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration.
by: Lamine Traoré, et al.
Published: (2018)

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
by: Sarah E Burr, et al.
Published: (2013)

Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
by: Benjamin G Koudou, et al.
Published: (2018)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
by: Jeremy D Keenan, et al.
Published: (2019)

Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.
by: Elizabeth N Ssemanda, et al.
Published: (2012)

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013)

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.
by: Athumani M Ramadhani, et al.
Published: (2016)

Elimination of active trachoma after two topical mass treatments with azithromycin 1.5% eye drops.
by: Abdou Amza, et al.
Published: (2010)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
by: Athumani M Ramadhani, et al.
Published: (2019)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
by: Michael Marks, et al.
Published: (2016)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013)

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
by: Tigist Astale, et al.
Published: (2018)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
Published: (2013)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
by: Harry Pickering, et al.
Published: (2022)

Pregnancy-related morbidity and risk factors for fatal foetal outcomes in the Taabo health and demographic surveillance system, Côte d'Ivoire
by: Siaka Koné, et al.
Published: (2018)

Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis: A comparative cross-sectional investigation in Côte d'Ivoire
by: Hope Simpson, et al.
Published: (2022)